Astrazeneca Pharma India Ltd.

ASTRAZEN Share PricePharmaceuticals & Drugs

9,203

85 (0.9%)

As on December 4, 2025

Exchange Scrips: BSE506820NSEASTRAZENISININE203A01020

Market Cap22,885 Cr

P/E Ratio 198.79

Dividend Yield 0.17 %

Performance

Market performance

Open9,091
High9,264
Volumes7,411
Prev9,203
Low9,071
As on2025-12-04

Historical performance

1 Year High10,691
3 Year High10,691
5 Year High10,691
1 Year Low6,312.75
3 Year Low3,098
5 Year Low2,445.7

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
22,885
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
198.79
Dividend Yield
Dividend Yield
0.17 %

Investment Returns

1 Year
38.1%
3 Years
180.8%
5 Years
104.2%
10 Years
733.5%

Technicals

IndicatorsValueSignal
5-DMA9,111.2Bullish
10-DMA9,064.65Bullish
20-DMA9,100.23Bullish
50-DMA9,183.52Bullish
100-DMA9,025.4Bullish
200-DMA8,701.81Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters11111
Foreign Investors11111
Domestic Investors---------------
Public Investors3291334377324652732127614
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 198.79.
  • 3Y Stock Price CAGR of the stock is 40.7.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹2946 Million.
  • The company generated revenue of ₹17163 Million in the previous financial year.

Astrazeneca Pharma India Ltd.

920385   (0.9%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1389320.8
No. of Shares: 151 (Approx)
Performance:38.9%
P/L: ₹389320.8

Top Gainers

SymbolChange%
SMCGLOBAL73.48(20%)
MAGNUM24.77(19%)
TOTAL86.05(17%)
NECLIFE20.94(17%)
ELDEHSG951(14%)

Top Losers

SymbolChange%
EMMVEE219.86(-9%)
POWERINDIA20085(-8%)
DAVANGERE3.87(-8%)
ONMOBILE58.3(-7%)
DUCON3.67(-7%)
BEDMUTHA101.23(-7%)
AVG176.08(-6%)
KAYNES4978(-6%)

Peer Comparison

Venus Remedies Ltd.

72.4%

764.15

1 Month Performance

Nectar Lifesciences Ltd.

49.5%

20.94

1 Month Performance

Ortin Global Ltd.

26.9%

14.49

1 Month Performance

Natco Pharma Ltd.

15.8%

949.25

1 Month Performance

SMS Pharmaceuticals Ltd.

14.8%

322.45

1 Month Performance

Ipca Laboratories Ltd.

12.3%

1454.6

1 Month Performance

Haleos Labs Ltd.

11.4%

1315.1

1 Month Performance

Gufic Biosciences Ltd.

9.5%

358.15

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month